Metraipolis › archive › dc_8fe970543eef

Evaluating commercial multimodal AI for diabetic eye screening and implications for an alternative regulatory pathway — Europe PMC PMID:41398461

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41398461
DOI
10.1038/s41746-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-10-08T16:18:05.804Z
SHA-256 of the archived text
77ca55cb53e9de049c59400c4e1876bd3908662968e249234dd7fa971e51691a
Stable URL of this page
https://metraipolis.com/documento/dc_8fe970543eef

How to cite

Evaluating commercial multimodal AI for diabetic eye screening and implications for an alternative regulatory pathway — Europe PMC PMID:41398461 — Europe PMC (en), https://europepmc.org/article/MED/41398461 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8fe970543eef (Metraipolis archive dc_8fe970543eef, sha256 77ca55cb53e9de049c59400c4e1876bd3908662968e249234dd7fa971e51691a)
BibTeX
@misc{dc8fe970543eef,
  title = {Evaluating commercial multimodal AI for diabetic eye screening and implications for an alternative regulatory pathway — Europe PMC PMID:41398461},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41398461},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8fe970543eef; sha256 77ca55cb53e9de049c59400c4e1876bd3908662968e249234dd7fa971e51691a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41398461. Agents can read the archived copy with the MCP tool read_document.